ABT-263 Reduces Hypertrophic Scars by Targeting Apoptosis of Myofibroblasts

Background: Inhibiting proliferation and inducing apoptosis of myofibroblasts is becoming one of the promising and effective ways to treat hypertrophic scar. ABT-263, as an orally bioavailable BCL-2 family inhibitor, has showed great antitumor characteristics by targeting tumor cell apoptosis. The o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaolan, Xiao, Yongqiang, Zhong, Chenjian, Shu, Futing, Xiao, Shichu, Zheng, Yongjun, Xia, Zhaofan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840494/
https://www.ncbi.nlm.nih.gov/pubmed/33519480
http://dx.doi.org/10.3389/fphar.2020.615505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840494/
https://www.ncbi.nlm.nih.gov/pubmed/33519480
http://dx.doi.org/10.3389/fphar.2020.615505

Ejemplares similares